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The Editorial on the Research Topic
Vascular Inflammation in Systemic Autoimmunity
The immune system evolutionarily arises to integrate distant tissues and coordinate responses 
toward environmental or endogenous threats in complex living beings (1). To this purpose, innate 
and adaptive immune cells exploit the vast network provided by the vasculature, which enables 
information exchange and physical communication between threatened tissues and tissues in charge 
of immune cell generation and maturation as well as metabolism regulation (2). Clinical evidence of 
vascular inflammation can be easily found in settings of persisting inflammation and autoimmun-
ity. Conversely, inflammation is a hallmark of disease progression in metabolic and cardiovascular 
diseases, which are the major causes of morbidity and mortality in the general population (3). 
If we translate these evidences into a prospect toward the future of research and clinical practice in 
immunology, two main questions arise:
• Can we identify shared pathogenic events among apparently unrelated human diseases that lead 
to vascular inflammation?
• Can we tackle these events to improve patient diagnosis, risk stratification, and treatment?
Although we are still far from satisfactorily answering these questions, here we highlight some of 
the emerging connections between vascular inflammation and systemic autoimmunity.
The first set of articles draws attention to some emerging players in the development and the 
maintenance of vascular inflammation (Figure 1). Khaib Dit Naib et al. report on the role of IL10 
promoter variants in the susceptibility to Behçet’s disease, adding evidence to the postulate of a 
common pathogenic background between Behçet’s disease and other autoinflammatory condi-
tions, such as Crohn’s disease (4–6), where platelet activation and smoldering vascular inflam-
mation may occur (7, 8). Additional hints on common genetic patterns of susceptibility among 
diseases characterized by vessel inflammation are emerging from multicenter studies (9). Bonatti 
et al. and Pattanaik et al. provide a thorough and updated appraisal on this topic by analyzing 
two paradigmatic conditions: anti-neutrophil cytoplasmic antibodies-associated vasculitides and 
systemic sclerosis, the former being characterized by necrotizing vessel inflammation, the latter 
by chronic vessel remodeling.
Maugeri et al. and Piotti et al. touch the pathophysiology of vascular inflammation and elegantly 
discuss the role of a tripartite innate immune network composed of the endothelium, platelets, and 
neutrophils in triggering and maintaining vessel injury as well as thromboembolic complications. 
In parallel, the articles by Hilhorst et al. and Lintermans et al. taken together constitute a compre-
hensive, cross-sectional analysis of the role of T-cells and macrophage/T-cells interactions in a wide 
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range of inflammatory conditions, from autoimmune diseases to 
atherosclerosis.
The article by Piotti and colleagues and the ones by Gioffredi 
et al. and Pattanaik et al. demonstrate how these core mechanisms 
deploy in clinical settings, such as renal transplant rejection, 
eosinophilic granulomatosis with polyangiitis, and systemic 
sclerosis (Pattanaik et  al.; Piotti et  al.; Gioffredi et  al.). Along 
with this line, Ammirati et  al. discuss how increasing insight 
about the pathogenesis of vessel inflammation could be translated 
into clinical practice through the development of novel imaging 
techniques as well as novel biomarkers. The article by Luqmani 
moves further from bench toward bedside by reporting most 
updated therapeutic strategies to contrast vessel inflammation 
and by critically discussing current therapeutic aims and clinical 
tools to be considered in the treatment of systemic vasculitides, 
based on most recent pathogenic achievements.
In summary, we are glad to introduce the reader to this 
translational research topic on vascular inflammation in systemic 
autoimmunity, a bird’s eye view on current research trends and, in 
our mind, a stimulus for discussion and for future deeper investi-
gation on the way the blood vessel and immune cells cooperate to 
determine vessel injury and inflammation. We really feel that this 
field – which had been so rewarding for scientists in the last dec-
ades – holds promises for major breakthroughs in the next future.
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